Great biologics deserve better formulation.
BioOrbit overcomes the concentration, stability, and delivery barriers holding them back.
ULTRA HIGH CONCENTRATION
Enable higher-concentration formulations with reduced viscosity and aggregation.
STABILITY BY DESIGN
Improve thermal stability, extend shelf life and reduce cold-chain reliance.
ENHANCED BIOAVAILABILITY
Optimise crystal morphology for controlled release and improved bioavailability.
The Breakthrough Is the Crystal.
Engineered crystal forms unlock new possibilities beyond the limits of existing manufacturing methods.
UNLOCK NEW INTELLECTUAL PROPERTY
Patent Cliff Protection
Extend exclusivity through differentiated crystal formulations beyond core patent expiry.
Generate New IP
Create novel crystal forms with new patenting potential through advanced crystallisation.
EXPAND MARKET OPPORTUNITY
Broaden Patient Access
Enable more practical delivery formats for wider patient adoption.
Unlock New Revenue Streams
Expand commercial potential through differentiated administration pathways.
INCREASE ASSET VALUE
Enhance molecule attractiveness through improved formulation performance and broader commercial potential.
Turning complex biologics into accessible therapies, enabling real patient access at scale